Democratic lawmakers are circulating a proposal that would allow non-psychoactive cannabidiol oil to be manufactured in the state of Wisconsin, arguing a bill approved by the Senate last week doesn't go far enough.
The bill, authored by Sen. Chris Larson, D-Milwaukee, and Rep. Jimmy Anderson, D-Fitchburg, would establish a licensure program for individuals to produce and distribute CBD oil.
Assembly lawmakers held a hearing on the Senate-approved version Wednesday. That bill allows patients to possess CBD oil without facing a state penalty if they have certification from their doctor, but doesn't allow for its sale or manufacture in Wisconsin.
Democratic lawmakers on the Assembly Committee on Children and Families questioned how people could acquire CBD oil.
"Without having dispensaries in Wisconsin, I'm worried this is not the complete fix," said Rep. Jill Billings, D-La Crosse.
But the bill's authors said patients could purchase CBD oil online and in some neighboring states. Sen. Van Wanggaard, R-Racine, said they considered including dispensaries. But he wanted to avoid regulation.
"If we took it to the regulators, we would never get this passed, not with the mindset of everybody at this point," he said. "I think the first thing we need to do is take away that fear from parents."
The Senate has approved a proposal that would lift state penalties for possession of a drug derived from marijuana used to treat seizures in children.
The bill passed 31-1, with Sen. Duey Stroebel, R-Saukville, casting the no vote. An Assembly Committee is set to take up the proposal next week.
The bill, which is similar to a proposal that was blocked from passage in the Senate last year, would allow patients to possess CBD oil without facing a state penalty if they have certification from their doctor. The federal government has designated the drug Schedule I, still making it illegal.
"Parents shouldn't have to risk jail time to treat their children," the bill's author, Sen. Van Wanggaard, R-Racine, said in a statement. "It is a sense of relief that we can ease the suffering and fear that too many parents experience trying to improve the lives of their children."
As you know, physicians are often assigned a role with a hospital or health system’s quality department or committee or asked to lead a quality improvement project.
The Wisconsin Hospital Association (WHA) has developed an important resource for physicians and advance practice providers who have an assigned role related to quality measurement and improvement within a WHA member hospital or health system. The WHA Physician Quality Academy will provide physicians the opportunity to increase their knowledge of quality improvement tools and principles; therefore, increasing the likelihood that a physician will be more successful in and comfortable with this leadership role.
The Academy offers two non-consecutive days of in-person training and access to supporting resources both between and after the live sessions.
As part of the Academy, participants will learn to:
The Academy is offered twice in 2017 (dates below), allowing physicians associated with a WHA member hospital/health system to choose the cohort that works best for his/her schedule. Attendance will be limited to the first 100 registrants per cohort, so if interested, register today at http://www.cvent.com/d/wvq5nm.
Increasing prescription drug costs have caught the attention of the President and the public. What's behind the rapid rise and how far are lawmakers willing to go?
Would allowing Medicare to negotiate with drugmakers make an impact? What about cutting taxes and regulations? And would lower prices mean less innovation? Learn more at a Wisconsin Health News Panel Event March 7 at the Madison Club (register now). Panelists:
AAN members can now join the new Neurohealth & Integrative Neurology Section and Synapse online community. The new section will be a forum to connect neurologists and practitioners who recognize the need to investigate therapies which may have potential to preserve neurologic health, promote neurologic recovery, and increase patient wellness, including non‐pharmaceutical and complementary treatments.
Membership renewal rates were strong for 2016. The goals for the number of dues-paying US neurologists and retention rate of dues-paying US neurologists were met, along with goals for retention of Early Career members and the number of medical students.
The goal was also met for the number of members applying for Fellow status with the AAN during 2016, with a total of 217 applications submitted.
The 2016 Practice Management Webinar series ended strong with a total of 637 unique registrations, which is 113 higher than 2015. The series concluded with a free webinar on MACRA and the 2017 Medicare physician fee schedule; view a Q&A document on these topics. On January 18, the 2017 series of webinars began, including recurring and new topics such as advance care planning, contracting, and coding for risk. Click here for the full list.
For more information on AAN practice resources, visit our webpage.
The AAN has met its goals for BrainPAC for 2016, in both the number of unique donors and total contributions. BrainPAC, the only political action committee in Washington dedicated to neurology, contributed to 125 candidates up for election in 2016, and 92 percent of those candidates were successful. Roughly 50 percent of the funds go to each side of the political aisle.
AAN efforts helped to cancel a Medicare Part B drug payment model. CMS announced in December that it will not finalize the drug payment model, a demonstration intended to cut costs by changing how physicians are reimbursed for the use of Medicare Part B drugs. The AAN helped lead the effort to fight this demonstration, which would have had an impact on a number of neurology practice groups.
Rep. Tom Price, nominee for Secretary of Health and Human Services, referred to the benefits of stroke telemedicine provided by a neurologist during his confirmation hearing. When asked about the future of telemedicine he responded: “Telemedicine is one of those exciting innovations that I believe will allow for individuals to access resources from a clinical standpoint…There is a neurologist that works with telemedicine and has a network of clinics and hospitals around the state. If somebody comes in with symptoms of a stroke that physician is able to see the patient in real-time and determine whether or not they have having a stroke…Telemedicine is absolutely vital.”
AAN President Terrence L. Cascino, MD, FAAN; President Elect Ralph L. Sacco, MD, MS, FAHA, FAAN; and Executive Director and CEO Catherine M. Rydell, CAE, met with several members of Congress on the first day of the 115th Congress to ensure that issues affecting the practice of neurology would remain a top legislative priority. Learn more in Capitol Hill Report and continue to check Capitol Hill Report for updates on the transition in Washington and how it may affect neurology.
Stay up-to-date on #AANAdvocacy by reading the Capitol Hill Report and following the AAN’s Senior Legislative Counsel Mike Amery on Twitter at @MikeAmeryDC.
Telemedicine continues to be an important issue on the state level. 29 states currently have a telemedicine parity law and more likely to join during the 2017 legislative session. The AMA recently wrote an interesting article on where telemedicine has been, where its headed.
For California residents, the new year brings new concussion protocols for children of all ages who participate in sports. Young athletes who sustain concussions now have to go through the same return-to-play protocol as high school and college athletes.The player is not allowed to return until a medical professional clears him or her of being symptom free for a minimum of 24 hours.This expansion of ‘return-to-play’ protocol is expected to be introduced in multiple states in 2017, more to come.
The number of states that have adopted the Interstate Medical Licensure Compact stands at 18. 5 states currently have active legislation, which the AAN is supporting. The compact offers an expedited licensing process for physicians interested in practicing medicine in multiple states. Wondering how the compact works? Check out this short video!
If you have any questions or would like to discuss how to improve your advocacy efforts, contact Grant Niver.
For the third time in as many state legislative sessions, a bill has been introduced related to cannabidiol (CBD) oil—one of the main active chemical compounds founds in marijuana. The proposal—being circulated for legislative sponsors before it is officially introduced—is designed to prevent state or local prosecution for possession of CBD oil if a physician certifies that a patient has a certain malady. The bill’s main sponsors are State Senators Van Wanggaard (R-Racine), Bob Wirch (D-Kenosha) and State Assembly Representative Scott Krug (R-Nekoosa).
Previous legislation allowed CBD oil to be dispensed by a State of Wisconsin Controlled Substances Board-approved pharmacy or physician if the product was to be used as part of an FDA-approved clinical trial. That requirement has been circumvented for the most part due to the lack of clinical trials on the Schedule I substance. Under the bill, a person will be allowed to possess CBD oil if a physician has certified within the past year that the CBD oil is for treating a seizure disorder.
The law would require that the physician certification—in the form of a letter or other document – include:
· Name, address and telephone number of the physician.
· Name and address of the patient who is issued the certification.
· The date the certification is issued.
Public hearings on the proposals could come as early as this month, with committee votes and possible full State Assembly and State Senate action thereafter.
The Wisconsin Department of Safety and Professional Services (DSPS) launched the new Wisconsin Enhanced Prescription Drug Monitoring Program (ePDMP) on Tuesday, replacing the former program.
2015 Act 266 requires physicians and other prescribers to review patient information from the ePDMP before issuing a prescription for any controlled substance beginning April 1, 2017. (More information, including exceptions to the requirement to consult the PDMP, in this nonpartisan Legislative Council memo.)
The following information is required to register for the ePDMP. (Previous logins will no longer work.)
· Last name.
· Last four digits of your social security number.
· License number.
· License type (profession).
· Specialty or primary area of practice.
· DEA number.
The ePDMP supports current browsers and two previous versions, except it only supports the current and previous version of Internet Explorer. If you experience issues, DSPS suggests that you update your browser.
Once the registration process is complete, users can begin looking up patients and managing delegates. The multistate search function will be available to both prescribers and their delegates as soon as their accounts are established. Training materials, including brief tutorial videos and information about creating and maintaining delegates are available at pdmp.wi.gov.
If you have questions or experience problems with the registration process, contact email@example.com.
563 Carter Court, Suite B, Kimberly, WI 54136
Phone: 920-560-5622 | Fax: 920-882-3655